Guess which ASX 200 share just upped its full-year dividend by 150%

The company offered investors 10 cents of dividends per share in FY22.

| More on:
excited young female in business attire and wearing glasses is holding up $100 notes in both hands.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX 200 share Nufarm is well and truly in the green today after posting its full-year earnings 
  • The company announced a 6 cent final dividend, bringing its full-year offerings to 10 cents per share – a 150% year on year improvement
  • It also revealed a 24% increase in underlying EBITDA, a 17% rise in revenue, and a 65% increase in NPAT 

Those invested in Nufarm Ltd (ASX: NUF) shares are likely having a good morning after the S&P/ASX 200 Index (ASX: XJO) crop protection and seed technology company upped its final dividend by 50%.

That leaves its financial year 2022 (FY22) full-year dividends 150% higher year-on-year at 10 cents per share.

The stock opened with a 1.2% lift that saw it trading at $5.60 before soaring to a current high of $5.93.

Right now, the Nufarm share price has eased slightly to trade at $5.89, marking an 8.67% increase.

ASX 200 share soars alongside its dividends

Here are the key takeaways from the ASX 200 company's full-year earnings:

Nufarm's final dividend, combined with the 4-cent interim dividend it announced in May – its first interim dividend since 2018 – saw it offering 10 cents per share over FY22.

The company's underlying NPAT also more than doubled last fiscal year – reaching $133.2 million.

It ended FY22 with $346 million of net debt and $863 million of net working capital.

What else happened in FY22?

Let's take a closer look at the results driving the ASX 200 share higher on Wednesday.

Nufarm's APAC segment posted. a 21% increase in underlying EBITDA, coming in at $135 million despite battling supply chain challenges in FY22.

Its North America business did even better. Its underlying EBITDA rose 42% to $148 million amid higher sale prices and strong demand for crop protection products.

Looking to Nufarm's European business, underlying EBITDA remained steady at $171 million as sales improved and regulatory headwinds took their toll.

Finally, the company's Seed Technologies business saw its underlying EBITDA lift 26% to $59 million. That was driven by demand for Nuseed's hybrid canola varieties, sorghum, and sunflower.

What did management say?

Nufarm managing director and CEO Greg Hunt commented on the company's full-year earnings, saying:

This result reflects the hard work we have done over recent years to reset the business, our focus on core products and key geographies together with our increased investment in innovation and sustainability.

Favourable seasonal conditions and attractive soft commodity prices generated strong demand for our seeds and crop protection products. Our seeds business continued to increase earnings as a result of strategic investments in innovative technologies.

We made significant progress on all our strategic growth initiatives across omega-3, bioenergy, seeds and crop protection; and we have a promising pipeline of opportunities.

What's next?

Nufarm didn't provide any solid FY23 earnings guidance today. Though, Hunt did reveal that "assuming normal seasonal conditions", the ASX 200 share expects to post modest underlying EBITDA growth this fiscal year. So far, conditions have remained favourable.

Looking further forward, however, the company is on track to grow its revenue to more than $4.6 billion in FY26. Hunt said:

Our revenue growth aspirations are supported by macro trends including the increasing demand for food from a rising global population, and the demand for sustainable agricultural practices to increase land productivity.

Nufarm share price outperforms ASX 200 in 2022

Today's gain included, the Nufarm share price has lifted 20% year to date. It's also trading for 17% more than it was this time last year.

For comparison, the index has fallen 6% in 2022 and 4% over the last 12 months.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
Healthcare Shares

3 ASX healthcare shares outperforming on quarterly updates

These stocks are charging ahead on an otherwise lacklustre trading day.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

ResMed share price jumps 10% on strong quarterly update

ResMed has impressed the market with its third-quarter update.

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Earnings Results

Bank of Queensland share price leaps 6% on improving outlook

ASX 200 investors are bidding up the Bank of Queensland share price on Wednesday.

Read more »

Photo of two women shopping.
Earnings Results

Premier Investments share price jumps 9% on results and demerger plans

The Smiggle and Peter Alexander owner has released its results. How did it perform?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Soul Patts share price struggles on falling profits

ASX 200 investment house Soul Patts reported its half year results this morning.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Brickworks share price tumbles on disappointing half-year loss

This loss didn't stop the company from increasing its dividend again.

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Earnings Results

ASX All Ords stock KMD tumbles as interim dividend cancelled

Investors are hitting the sell button on ASX All Ords stock KMD today.

Read more »